Company: MYGN
Filing Date: 2025-04-09
Form Type: DEF 14A
Source: 0000899923-25-000028
Chunk: 14

Company: MYRIAD GENETICS INC
Filing Date: 2025-04-09
Form: DEF 14A
Chunk 14
---
 and Corporate Responsibility Highlights (page 28)

Corporate responsibility is integral to our mission of developing transformative diagnostic tests that improve patients' lives. We believe our programs create value for patients, healthcare professionals, and stockholders while strengthening our communities and empowering employees.

As part of our 2023-2024 Quality, Innovation, and Corporate Responsibility Report, we disclosed our Scope 1 and Scope 2 emissions data. Moving forward, we plan to enhance our environmental footprint assessment and provide additional public disclosures on our environmental performance to our stockholders.

Some of our 2024 corporate responsibility highlights include:

• Patient Assistance : We are working to improve overall health care quality and increase access to diagnostic testing for those in need by offering robust financial assistance.

• Sustainability : Our Myriad Green Team engages employees in environmental initiatives that benefit local communities. We continue to recycle plastics in our laboratory facilities, and our new laboratories in west Salt Lake City, Utah and South San Francisco, California feature energy- and water-efficient designs.

• Employee Engagement : In 2024, 84% of our employees rated us as a Great Place to Work®. Our global voluntary employee turnover rate in 2024 was 10%.

• Caring and Belonging : As of December 31, 2024, women made up 64% of our workforce, 39% of leadership roles (vice president and above), and 33% of our Board members, including the Board Chair. We currently have seven employee-led resource groups (ERGs) that represent and support diverse communities in our workforce.

5

#### MYRIAD GENETICS, INC.

#### 322 North 2200 West

#### SALT LAKE CITY, UTAH 84116
<div align='center'>(801) 584-3600</div>

#### Proxy Statement For the Myriad Genetics, Inc.
2025 Annual Meeting of Stockholders to be held on June 5, 2025

This proxy statement, along with the accompanying Notice of 2025 Annual Meeting of Stockholders, contains information about the 2025 Annual Meeting of Stockholders of Myriad Genetics, Inc., including any adjournments or postponements of the annual meeting, which we refer to as the Annual Meeting. To attend the Annual Meeting please visit the following URL: www.virtualshareholdermeeting.com/MYGN2025. In this proxy statement, we refer to Myriad Genetics, Inc. as ‘‘Myriad,’’ "Myriad Genetics," ‘‘the Company,’’ ‘‘we